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a-Hydroxy alkanones were synthesised with high enantiomeric purity by stereoselective enzyme-catalysed
diketone reduction. Both diketone reduction and cofactor regeneration were accomplished with puriﬁed
carbonyl reductase from Candida parapsilosis (CPCR2). The reaction products were isolated by column
chromatography and analysed by chiral GC measurements, 1H-NMR spectroscopy and determination of
optical rotations. Preparative-scale biotransformations yielded 350–600 mg of pure aliphatic a-hydroxy
ketones including the diﬃcult to obtain (S)-2-hydroxypentane-3-one. For all the products good
enantiomeric excesses in the range of 89–93% were achieved.Introduction
Chiral a-hydroxy ketones are important and valuable building
blocks for the synthesis of several diﬀerent pharmaceuticals
such as anti-depressants and fungicides.1 They contain a chiral
centre at the carbon atom of the hydroxy function, and in case
of unequal substituents at the carbonyl and the hydroxy moiety
not only enantiomers, but also structural isomers occur. Thus,
synthesis of this type of compound requires regio- as well as
stereoselective approaches.
Presently, various organochemical methods for the synthesis
of a-hydroxy ketones are available. Examples are ranging from
peroxy acid catalysed oxidations2 to metal catalysed diketone
reductions applying zinc3 or titan iodide.4 Some catalysts, such
as transition metal complexes, exhibit a notable regio- and
stereoselectivity, mostly, however, restricted to phenyl-
substituted hydroxy ketones.5–11 Linear aliphatic a-hydroxy
ketones comprise particularly challenging targets due to the
structural similarity of the substituents.
In recent years, diﬀerent biocatalytic approaches for the
production of a-hydroxy ketones have been introduced as
alternatives to chemical methods, including the use of isolated
enzymes such as lipases, lyases, and oxidoreductases.1,12,13
Lyases have been successfully applied in the synthesis of
symmetric a-hydroxy ketones such as acetoin14 and pro-
pioin.15–17 Utilizing a lyase and decarboxylase in cascade, some
non-symmetric compounds could also be synthesized.18 With
lipases, kinetic resolutions of esters were conducted yielding
enantiopure aliphatic a-hydroxy ketones especially for largerof Microbiology, Technische Universita¨t
tu-dresden.de
tion (ESI) available. See DOI:
hemistry 2015substituents.19 The application of alcohol dehydrogenases for
the synthesis of aliphatic a-hydroxy ketones by means of diol
oxidation20,21 or diketone reduction,21–23 was demonstrated. In
these enzymatic processes enantiomeric excesses between 90
and 99% were achieved. If determined, isolated yields ranged
between 23 and 70%. However, especially the diketone reduc-
tion has not been suﬃciently exploited for eﬃcient preparation
of a-hydroxy ketones so far.1
Here, we demonstrate the application of a carbonyl reduc-
tase from Candida parapsilosis CPCR2 (ref. 24–27) for the highly
selective asymmetric reduction of prochiral linear aliphatic
diketones to a set of corresponding (S)-congured a-hydroxy
ketones in preparative scale. At the same time, the required
cofactor nicotinamide adenine dinucleotide (NADH) was eﬃ-
ciently regenerated by oxidation of isopropyl alcohol with
CPCR2 (Fig. 1). The reaction products were puried by silica gel
chromatography and analysed via gas chromatography,
1H-NMR spectroscopy and determination of optical rotation.Fig. 1 Reduction of 2,3-alkanedione substrates to the corresponding
(S)-2-hydroxy alkan-(3)-ones catalysed by CPCR2. Cofactor regen-
eration is achieved by oxidation of the co-substrate isopropyl alcohol
to acetone, also catalysed by CPCR2.
RSC Adv., 2015, 5, 38271–38276 | 38271
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View Article OnlineThe absolute conguration was determined via 1H-NMR anal-
ysis of Mosher's esters obtained from the reaction products.Fig. 2 Progress of 2,3-alkanedione reduction and corresponding
product formation in preparative scale biotransformations. (A) 2,3-
Pentanedione, (B) 2,3-hexanedione, (C) 2,3-heptanedione.Results and discussion
For a-diketone substrates with varying structural determinants
and therefore varying potential for reduction by CPCR2, the
specic catalytic activity of the enzyme was investigated. A
selection of results is shown in Table 1. It was found that cyclic
diketones were not accepted at all, and substrates with
substituents larger than a methyl group next to both carbonyl
functions were converted with only low reaction rates. Aliphatic
diketones comprising one methyl group next to the carbonyl
functions, on the other hand, were converted with reaction rates
up to 10 U mg1, which is quite good. Accordingly, 2,3-alka-
nedione substrates were investigated for biotransformation in
preparative scale.
Preparative-scale biotransformations were successfully con-
ducted for 2,3-pentanedione, 2,3-hexanedione, and 2,3-hepta-
nedione (entries 1a, 2a and 3a, respectively, in Table 1).
Conversions between 88 and 97% were observed within only
30 minutes (Fig. 2). The yields aer 1 h of reaction time ranged
between 70 and 87%. Next to the formation of the main
(S)-product very small amounts of the (R)-product were detec-
ted, leading to decent enantiomeric excesses (ee-values) (Table
2). Taking both chiral products into account the mass balance
of the reactions is imbalanced by 7–19% on the product side.
This divergence between the measured decrease of substrate
and increase of product may be explained by the substrate
evaporation and adsorption to the reaction vessel, and a light-
induced side-reaction of diketones as described by Ma¨kinen
and co-workers.28
Aer completion of the reaction aer one hour, the reactants
were retrieved by a four-fold extraction with equal volumes of
ethyl acetate. Purication of the reaction products by column
chromatography yielded highly pure fractions of the 2-hydroxy-
alkan-3-ones. Aer solvent removal 1H-NMR analysis was con-
ducted showing no major impurities in the reaction products
(ESI, Fig. S4–S6†). Hence, for the investigated group of
substrates, the reaction is chemoselective regarding the reduc-
tion of diketones to hydroxy ketones, and regioselective
regarding the carbonyl function on C2-position. In addition, the
reaction is stereoselective, yielding ee-values between 89 and
95% (Table 2). A signicant eﬀect of the reaction parameters
temperature, pH-value and cosubstrate concentration was not
observed (Fig. S7†).Table 1 Speciﬁc catalytic activity of CPCR2 in the reduction of
diketones
Substrate Spec. activity [U mg1]
2,3-Pentanedione (1a) 10.0  0.3
2,3-Hexanedione (2a) 8.9  0.2
2,3-Heptanedione (3a) 9.1  0.1
3,4-Hexanedione 1.7  0.1
1,2-Cyclohexane-dione 0.0  0.0
38272 | RSC Adv., 2015, 5, 38271–38276Performance of cofactor regeneration by using isopropyl
alcohol as co-substrate eﬀectively supplied the reaction with
reduced cofactor. Turnover numbers (TONs) of NADHwere 300–
450 (Table 3), which is a reasonable range. Improvement would
certainly be possible by decreasing NADH concentration, but
most probably at the cost of reaction rates. The TON of the
enzyme was in the order of 105, which is excellent and a good
measure for the eﬃciency of the catalyst.29 The procedure yiel-
ded 360–600 mg of the pure (S)-a-hydroxy ketones, corre-
sponding to isolated yields between 36–46%. On the one hand,
these low values may be explained by the factors already dis-
cussed for the reaction yield. On the other hand the purication
of the products by silica gel chromatography was not optimized
and specically diﬃcult for the short hydrophilic substrates.
Nevertheless, high space time yields (STY) between 43 and 72 gThis journal is © The Royal Society of Chemistry 2015
Table 2 Conversion, reaction yield, enantiomeric excess and isolated yield of 2,3-alkanedione reduction with CPCR2 on a preparative scale
Entry Product Conversiona [%] Reaction yieldb [%] ee [%] Yield [mg] Isolated yield [%]
1b 97.1  0.2 75.5  1.2 94.8  1.2 362 36.2
2b 97.7  0.1 87.0  0.5 93.5  1.3 529 46.3
3b 89.5  0.1 70.4  0.3 88.7  0.8 601 46.9
a Substrate consumption aer 1 h, measured via GC. b Product concentration aer 1 h, measured via GC.
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View Article Onlineper L per day were achieved (Table 3), mainly due to the fast
conversion of substrates.
For determination of the absolute conguration of the main
products, Mosher's esters of the reaction products were syn-
thesised and analysed via 1H-NMR.30 This method is based on
an anisotropic eﬀect of a phenyl group in the derivatization
agent MTPA on the chemical shi of the protons in the
substituents of a target hydroxyl compound. Both, the (R)- and
(S)-MTPA esters of each reaction product were synthesized and
1H-NMR spectra were recorded. The diﬀerences between the
chemical shis for protons, in the same position in both esters,
are descried as Dd values. For all reaction products, these Dd
values could only be determined for the protons on C1-position,
ranging between 0.05 and 0.06 ppm (Table 4). Considering
the spatial position of the MTPA-phenyl group, the position of
the small substituent relative to the large substituent could be
determined, yielding (S)-conguration at the hydroxy group.30
Results of the analysis are illustrated in the ESI (Fig. S8–S10†).
The optical rotation of the reaction products was measured
applying the conditions described by Martre and coworkers
([a]25D (c¼ 0.9, chloroform)11). With +43.8 the optical rotation of
(S)-2-hydroxy-pentane-(3)-one is in good agreement with +48,
determined in the reference study11 (Table 4). With +52.0 forTable 3 Process relevant data from preparative scale biotransforma-
tions of diketones to the corresponding chiral a-hydroxy ketones.
Turnover numbers (TON) for biocatalyst and cofactor, and space time
yield (STY) of the reaction
Product TON NADH TON CPCR2 STY [g per L per day]
1b 297 2.8  105 43
2b 447 4.2  105 64
3b 351 3.3  105 72
This journal is © The Royal Society of Chemistry 2015(S)-2-hydroxy-hexane-(3)-one and +59.2 (S)-2-hydroxy-heptane-
(3)-one, the reaction products exhibited increasing optical
rotations with increasing size of the large substituent. For
(S)-2-hydroxy-hexane-(3)-one the measurement was repeated
under the conditions applied by Bortolini and coworkers ([a]20D
(c ¼ 2.5, chloroform)23) The measured value of +55.2 is in good
agreement with the reference (57 (ref. 23)). In case of
(S)-2-hydroxy-heptane-(3)-one, no reference value was detected.
Thus, where available, the measured optical rotations were
comparable to literature, with a tendency to lower values. This
may be explained by enantiomeric impurities resulting from the
biotransformation.
Summarising, the asymmetric reduction of three diﬀerent
2,3-alkanediones with CPCR2 yielded the corresponding
(S)-2-hydroxy-alkane-3-ones with good enantiomeric excesses.
Due to a considerably small substrate binding pocket,25 the
substrate specicity of CPCR2 restricts its application to
compounds with a carbonyl group on C2-position, which on the
other hand allows a highly regioselective reduction of asym-
metric diketones. In addition, no consecutive reduction of the
hydroxy ketone to the corresponding diol was observed asTable 4 Chemical shifts and DdSR values (in ppm) for hydrogen atoms
at C1-position of hydroxy ketones and corresponding Mosher's esters
Product
Hydroxy
ketone (R)-Ester (S)-Ester DdSR
Optical
rotation
1b 1.34 1.43 1.49 0.06 +43.8  1.3a
2b 1.34 1.43 1.48 0.05 +52.0  1.3a/
+55.2  2.5b
3b 1.34 1.43 1.49 0.05 +59.2  1.9a
a Measured at [a]25D (c ¼ 0.9, chloroform). b Measured at [a]20D (c ¼ 2.5,
chloroform).
RSC Adv., 2015, 5, 38271–38276 | 38273
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View Article Onlinedescribed in previous studies with ADHs.20,21 Here again the
limitation of the substrate scope of the enzyme is turned into an
advantage since the reaction selectively stops at the hydroxy
ketone level. Thus, low molecular weight a-hydroxy ketones,
containing the hydroxy function on C2-position, may be syn-
thesised chemo-, regio- and stereoselectively utilising CPCR2.
In contrast, the application of lipases for the synthesis of
aliphatic hydroxy ketones shows improving enantiomeric
excesses with an increasing size of both substituents.19 This is
also true for lyases, where symmetric a-hydroxy ketones with
C5-substitutents were synthesized with the highest enantio-
meric excesses.17 Thus, the comparably small substrate scope of
the asymmetric diketone reduction with CPCR2 is compensated
by the fact that the products obtained in this study are diﬃcult
to synthesize applying other enzymatic approaches.Experimental section
If not stated otherwise all chemicals were purchased from
Sigma-Aldrich (St. Louis, USA). All reactions were performed in
aqueous solution.Enzyme preparation and characterization
CPCR2 was prepared according to a modied protocol of Jako-
blinnert et al.27 Fermentation was performed in 1 L scale in LB
medium with ampicillin (100 mg mL1) in a stirred tank reactor
(Biostat B Plus, Sartorius, Germany). The medium was inocu-
lated from a preculture of E. coli BL21 (DE3) containing the
plasmid pET22b(+):CPCR2 to a nal OD600 of 0.1. Temperature
(37 C), pH (7.0) and dissolved oxygen (50%) were controlled
automatically. Aer reaching an OD600 of 0.8, the temperature
was reduced to 20 C and protein expression was induced with
IPTG (isopropyl b-D-1-thiogalactopyranoside) at a nal concen-
tration of 0.1 mmol L1. Aer 4 hours incubation, cells were
harvested by centrifugation (10 min, 5000g, 4 C).
For cell lysis, the cell pellet was resuspended in 30 mL trie-
thanolamine (TEA) buﬀer (100 mmol L1, pH ¼ 8.0) adding
50 mg mL1 DNaseI (Applichem GmbH, Germany), 500 mg mL1
lysozyme and 1 mmol L1 phenylmethylsulfonyl uoride
(PMSF). The lysate was cleared by centrifugation (20 min,
16 000g, 4 C). CPCR2 was puried by StrepTag aﬃnity chro-
matography applying a fast protein liquid chromatography
system (A¨kta 920, General Electrics, USA) equipped with a 5 mL
StrepTrap® column (General Electrics, USA) according to
modied manufacturer's instructions. As washing buﬀer, a TEA
buﬀer (100 mmol L1, pH ¼ 8.5) with 500 mmol L1 sodium
chloride, 10% (v/v) glycerol, and 1 mmol L1 ethylene diamine
tetra acetic acid (EDTA) was applied. For elution a TEA buﬀer
(100 mmol L1, pH ¼ 8.5) with 500 mmol L1 NaCl, 10% (v/v)
glycerol, and 2.5 mmol L1 desthiobiotin was used.
CPCR2 concentration for determination of specic activities
was quantied via BCA-assay (Pierce, USA) according to the
manufacturer's instructions. Enzyme activity assays were per-
formed at 25 C with 6.2 mg mL1 CPCR2 in 1 mL TEA buﬀer
(100 mmol L1, pH 7.3) applying 3 mmol L1 substrate. Reac-
tions were started by addition of nicotinamide adenine38274 | RSC Adv., 2015, 5, 38271–38276dinucleotide (NADH) to a nal concentration of 250 mmol L1.
For all substrates the initial reaction rate was measured
photometrically at 340 nm for 2 minutes. Measurements were
performed in triplicates.
For determination of stereoselectivity, activity assays were
performed on 500 mL-scale. The reaction mixture, containing
25 mmol L1 of substrate (1(a): 480 ng, 2(a): 533 ng, 3(a):
590 ng), 250 mmol L1 NADH, 5% (v/v) isopropyl alcohol and
4 mmol L1 dithiothreitol (DDT) in TEA buﬀer (100 mmol L1,
pH 7.3), was prepared and preincubated at 25 C for 5 min.
Conversion was started by addition of 1 mg mL1 CPCR2.
Reactions were performed at room temperature in a shaker
(Vibramax 110, Heidolph, Germany) at 1000 rpm for 30 min.
125 mL samples were withdrawn every 10 min and extracted with
125 mL ethyl acetate. Product concentrations were determined
via chiral GC.
Preparative biotransformation
Preparative biotransformations were conducted in 200mL-scale
in 500 mL shake-asks mixed with a magnetic stir bar (80 rpm)
at room temperature. The reaction mixture contained: CPCR2
8.5 mg mL1, substrate 50 mmol L1 (1(a): 961 mg, 2(a):
1066 mg, 3(a): 1179 mg), NADH 100 mmol L1, isopropyl alcohol
5% (v/v), TEA (100 mmol L1, pH 7.3), dithiothreitol (DDT)
4 mmol L1. Like for activity assays isopropyl alcohol acts as
cosubstrate for cofactor regeneration. 5% (v/v) isopropyl alcohol
corresponds to a concentration of 650 mmol L1 yielding a
13-fold excess of cosubstrate over the substrate. All components
except for CPCR2 were premixed under the given conditions
until the substrate was dissolved completely. Then the reaction
was initiated by the addition of CPCR2. The biotransformations
were stirred for one hour and samples were withdrawn at de-
nite time intervals (15 min) and extracted with one sample
volume of ethyl acetate. Conversion of substrates and synthesis
of products was assessed by GC.
Product purication and analytics
Reaction products were isolated by four consecutive extractions
with 200 mL of ethyl acetate. Purication was performed via
column chromatography using silica gel 60 (Sigma Aldrich,
Germany) as solid phase and a solvent mixture of n-hexane and
ethyl acetate at a ratio of 4 : 1 (compounds 2,3) and 1 : 1
(compound 1), respectively. Purication was monitored via GC
and thin layer chromatography (TLC) in combination with
cerium sulfate staining.
GC analysis of the reaction products was performed on a
Shimadzu GC2010 gas chromatograph with ame ionization
detector (FID) and an AOC20i Autosampler. For separation of all
chiral compounds Hydrodex g DIMOM (Macherey-Nagel, Ger-
many) was applied as solid phase using diﬀerent temperature
gradients for each compound. The carrier gas N2 was applied
with a pressure of 70 kPa. 2 mL of the extracted samples were
injected to the column without split ow. Exemplary chro-
matograms are provided in the ESI (Fig. S1–S3†).
2,3-Pentanedione. A temperature gradient from 95–115 C
was applied with a ramp of 2 C min1. Retention times wereThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinedetermined at 3.3 min for 2,3-pentanedione 1(a), 5.6 min for
(R)-2-hydroxy-pentan-(3)-one and 7.8 min for (S)-2-hydroxy-
pentan-(3)-one 1(b) (ESI, Fig. S1†).
2,3-Hexanedione. A temperature gradient from 98–122 C
was applied with a ramp of 2 C min1. Retention times were
determined at 3.8 min for 2,3-hexanedione 2(a), 8.6 min for
(R)-2-hydroxy-hexan-(3)-one and 9.2 min for (S)-2-hydroxy-
hexan-(3)-one 2(b) (ESI, Fig. S2†).
2,3-Heptanedione. A temperature gradient from 105–125 C
was applied with a ramp of 2 C min1. Retention times were
determined at 4.4 min for 2,3-heptanedione 2(a), 9.1 min for
(R)-2-hydroxy-heptan-(3)-one and 9.4 min for (S)-2-hydroxy-
heptan-(3)-one 2(b) (ESI, Fig. S3†).
Reaction products were identied via 1H-NMR spectroscopy
(500 MHz, Bruker DRX-500) using chloroform-d (1H: d 7.26).
1H-NMR spectra are provided in the ESI (Fig. S4–S6†).
(S)-2-Hydroxy-pentan-3-one (1b): [a]25D ¼ +43.8  1.3 (c¼ 0.9,
chloroform) yellowish oil, (1H-NMR, 500 MHz) d (ppm): 4.19
(1H, q, j ¼ 7.08, CH–OH), 3.40 (1H, bs, OH), 2.45 (2H, m, CH2),
1.32 (3H, d, j ¼ 7.07, CH3), 1.05 (3H, t, j ¼ 7.32, CH3), (ESI,
Fig. S4†)
Reference: [a]25D ¼ +48 (c ¼ 0.9, chloroform)11
(S)-2-Hydroxy-hexan-3-one (2b): [a]25D ¼ +52.0  1.3 (c ¼ 0.9,
chloroform), [a]20D ¼ +55.2  2.5 (c¼ 2.5, chloroform) yellowish
oil, (1H-NMR, 500 MHz) d (ppm): 4.23 (1H, q, j ¼ 7.08, CH–OH),
3.52 (1H, bs, OH), 2.45 (2H, m, CH2), 1.66 (2H, m, CH2), 1.38
(3H, d, j ¼ 7.08, CH3), 0.93 (3H, t, j ¼ 7.31, CH3), (ESI, Fig. S5†)
Reference: [a]20D ¼ +57 (c ¼ 2.5, chloroform)23
(S)-2-Hydroxy-heptan-3-one (3b): [a]25D ¼ +59.2  1.9 (c¼ 0.9,
chloroform) yellow oil, (1H-NMR, 500 MHz) d (ppm): 4.22 (1H, q,
j ¼ 7.09, CH–OH), 3.56 (1H, bs, OH), 2.45 (2H, m, CH2), 1.60
(2H, m, CH2), 1.35 (3H, d, j ¼ 7.14, CH3), 1.31 (2H, m, CH2),
0.89 (3H, t, j ¼ 7.35, CH3), (ESI, Fig. S6†).Absolute conguration of a-hydroxy ketones
The absolute conguration of reaction products was deter-
mined via 1H-NMR analysis of Mosher's esters of the products
according to the protocol of Hoye and coworkers (procedure:
1.b).30 In this method, chiral alcohols are esteried with both
enantiomers of a phenyl substituted chiral acid. Electrostatic
shielding eﬀects lead to a shi in the 1H-NMR-spectrum, which
can be correlated with the absolute conguration of the analysed
alcohol. The reaction was performed in dichloromethane-d (1H:
d 5.32) on 50 mg-scale. The synthesis of (S)-Mosher's esters of
hydroxy ketones was performed by esterication with the
(R)-MTPA-Cl ((R)-()-a-methoxy-a-(triuoro-methyl)phenylacetyl
chloride, Sigma-Aldrich, Germany), while esterication with
the (S)-MTPA-Cl gives rise to (R)-Mosher's esters. The absolute
conguration was then determined by comparison of the
1H-NMR spectra and the chemical shis of the two diastereo-
meric esters, and subsequent determination of DdSR.This journal is © The Royal Society of Chemistry 2015Conclusions
The asymmetric reduction of prochiral diketones with the
alcohol dehydrogenase CPCR2 proves to be a fast and eﬃcient
method for the synthesis of (S)-2-hydroxy alkanones and a good
addition to the existing biocatalytic approaches. While lyases
are good catalysts for the synthesis of symmetric hydroxy
ketones, lipases are suitable for higher molecular weight
compounds. Substrate scope and selectivity make the CPCR2 a
valuable biocatalyst for the synthesis of asymmetric low
molecular weight hydroxy ketones as described in this study,
signicantly improving the accessibility of this class of chiral
compounds by biochemical synthesis.
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